GlassScriptPhysician profile
Julius Alexander Hatcher, IV
NPI 1427899970
$1,444.75
in general payments reported to CMS, 2019-2025
12 companies · $1,082 in 2025
The $1,082 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $363 · 2025: $1,082.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $291.05 | 2024-2025 | Citrefix, Augment Injectable, Prostep |
| Organogenesis INC. | $133.27 | 2025 | Puraply Wound Matrix |
| Solventum Corporation | $131.04 | 2025 | V.A.C. Veraflo, Activ.A.C. |
| Kuros Biosciences USA, INC | $125.51 | 2024 | Magnetos |
| Vertex Pharmaceuticals Incorporated | $120.83 | 2025 | |
| Abbvie INC. | $115.55 | 2025 | |
| Smith+Nephew, INC. | $115.26 | 2025 | Oasis Micro, Stravix Mesh |
| Orthofix Medical, INC. | $113.16 | 2025 | Trinity Elite |
| Treace Medical Concepts, INC. | $99.79 | 2025 | |
| Alafair Biosciences, INC. | $91.88 | 2024 | Versawrap |
| Averitas Pharma INC. | $82.25 | 2025 | Qutenza |
| Paratek Pharmaceuticals, INC. | $25.16 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julius Hatcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.